GSK
GSK plc$52.15
LiveJun 17, 2026
Market cap
$104.53B
52w range
35.45 – 61.70
P / E
—
EPS
—
Volume
4.02M
Revenue · FY
—
Insider buys and sells are sourced from SEC Form 4 filings, which cover US-listed issuers. We don't have Form 4 history for this name.
| Insider | Role | Action | Shares | Price | Value | Trade date | Filing |
|---|---|---|---|---|---|---|---|
| No open-market insider activity in this window. | |||||||
Schedule 13D / 13G — investors holding more than 5% of GSK-US.
| Filed | Reporting person | Form | Type | Aggregate owned | % Class | Sole voting | Shared voting | Citizenship | |
|---|---|---|---|---|---|---|---|---|---|
| May 06, 2026 | FMR LLC | — | HC | — | +5.80% | 0 | 0 | DELAWARE | SEC → |
| Dec 05, 2025 | GSK plc | — | HC | — | 0.00% | 0 | 0 | X0 | SEC → |
| Aug 13, 2025 | GSK plc | — | HC | — | +74.00% | 16.59M | 0 | X0 | SEC → |
| Mar 28, 2025 | GSK PLC | — | CO | — | +16.40% | 9.19M | 0 | X0 | SEC → |
| Mar 07, 2025 | BlackRock, Inc. | — | HC | — | +8.90% | 0 | 0 | DELAWARE | SEC → |
| Feb 06, 2023 | GSK plc | — | CO | — | +4.90% | 1.01M | 0 | England and Wales | SEC → |
| Jan 30, 2023 | GSK plc | — | CO | — | +10.95% | 10.68M | 0 | England and Wales | SEC → |
| Nov 14, 2022 | GSK plc | — | CO | — | +19.99% | 9.19M | 0 | England and Wales | SEC → |
| Nov 04, 2022 | GSK plc | — | CO | — | +13.20% | 39.66M | 0 | — | SEC → |
| Jul 27, 2022 | GSK plc | — | CO | — | +12.94% | 502.73M | 1.2B | England and Wales | SEC → |
| Feb 10, 2022 | GlaxoSmithKline plc | — | CO | — | +12.60% | 30.25M | 0 | England and Wales | SEC → |
| Feb 10, 2022 | GlaxoSmithKline plc | — | CO | — | +6.50% | 8.55M | 0 | England and Wales | SEC → |
| Feb 10, 2022 | GlaxoSmithKline plc | — | CO | — | +3.90% | 802.63K | 0 | England and Wales | SEC → |
| Feb 10, 2022 | GlaxoSmithKline plc | — | CO | — | +9.90% | 5.86M | 0 | England and Wales | SEC → |
| Sep 27, 2021 | GlaxoSmithKline plc | — | CO | — | +4.50% | 1.79M | 0 | England and Wales | SEC → |
institutional_holders for GSK-US.